Large Cap Biopharmaceutical Metrics and Performance Q1 2025
Large Cap Biopharmaceuticals- Performance Metrics The best performing biopharma stocks YTD were: ABBV up 8.5%, AMGN up 11.8%, AZN up 12%, GILD up 12.7%, LLY up 9.4%, VRTX up 14%. The worst performing biopharmas YTD were: BMY down 4.7%, BIIB, down 10.2%, MRK down 16.6%, PFE. down 3.7%, REGN down...
SMID Biotech Stocks had a Good Week despite crosscurrents
SMID Biotech Stocks Rallied Nicely the Week of 2/13/25 Selected SMID life science stocks had a good week in a bifurcated market. Large cap biopharmas earnings have been strong and comprise the largest healthcare holdings in our portfolio. Political crosscurrents are a concern- uncertainty of...
BIG RAINS coming to SOCAL: Fourth Driest Season YTD
FORECAST https://www.laalmanac.com/weather/we13a.php#google_vignette Only 1.9 inches PPT in DT LOS ANGELES NOAA for LA County...
Healthcare and Biotech Playbook as Disruption Gathers Force…Update-3. Focus on SMIDs
Update-3 ....2/14/25...Happy Valentine's Day!... RISK ON for MOMENTUM Trades in SMID Life Science List.-Big MOVERS: ABSI, ARKG, BBIO, CRSP, DNLI,,GH, MNMD,PACB, RXRX,TEM, VCYT. We missed TEM up 29% in 5 days. Jumped into REGN too soon down 4.57% In 5 days. Update-2 ...2/12/25....The market is...
Can Biotech Stocks Survive the Precarious Macro?…Update-2…SMID weakness
Update-2 ...2/7 1;30 EST Risk off for SMID biotech caps on MACRO news and technicals. XBI down 2%.Renewed tariff threats. BIG tech feeling the heat on CHINA trade war? Consumer sentiment hits 7 month low. Update-1 2/4/25 315p EST...Nice little rally in biotech and MedTech: ABBV, LLY, RHHBY,...